Marginum – Next-generation technology for cancer surgery

Marginum is pioneering patent-pending tissue identification technologies for surgery, enabling safe and efficient monitoring of tumour tissues during operations and improving surgical performance and cost-effectiveness. The company was founded in 2020 by a team of professionals with a superior background in quantitative surgical techniques.
 
The first product’s idea emerged from internationally competitive research on optic tissue biomarkers at the University of Eastern Finland (UEF) and Kuopio University Hospital (KUH). The innovation enables surgeons to operate tumours more efficiently and can reduce the number of reoperations and harm caused to patients. The solution is scalable to address a global problem and suitable for both developed and emerging markets.
 
Derived from experimental state-of-the-art research, the products will detect tumour cells from surgical suction waste based on defined fluorescence. Surgical tissue monitoring increases tumour removal rates and patient safety by guiding surgeon’s decision-making during surgery. The innovation will result in decreased local cancer recurrence, improved patient care and diminished healthcare costs.

Marginum’s work has led to numerous technological breakthroughs and gained several academic and business awards. A catalyst for the UEF research team’s efforts was winning the Tahko Ski Lift Pitch 2022 pitching competition. In addition to the prize money and several new contacts from potential investors and business partners, Marginum was also featured at the iconic Nasdaq tower in New York Times Square, a significant milestone for the company.

We are pursuing market entry exceptionally fast – in 2024 – and work with industry-leading academic and clinical experts to ensure the safety, efficiency and clinical applicability of our technological solutions, says Samu Lehtonen, the company’s CEO.

Marginum warmly recommends the Tahko Ski Lift Pitch event to everyone interested in the start-up scene. Participation is highly encouraged especially for research teams considering commercializing their research. The event is excellent for networking with start-ups, investors and experts. Tahko skiing slopes also merit a visit on their own.
 
Additional information:
 
Samu Lehtonen
CEO, Marginum Ltd
samu.lehtonen@marginum.com
+358 40 579 7890
 
https://www.tahkoslp.com
 
https://www.uef.fi/en
 
https://www.marginum.com

The original article can be read on the Tahko Ski Lift Pitch website.